Phone
ClinicalTrials.gov URL
Acknowledgement
10 business days
Renibus Therapeutics, Inc.
Renibus Therapuetics, Inc.
EA Therapies for Single Patient
RBT-9 for the treatment of COVID-19 at the early stage (Stage I) of infection in patients who are at high risk for disease progression.
EA Policies for Single Patient
Renibus Therapeutics will evaluate and respond to a request that it receives on a case-by-case basis.